about
NeuroPace Inc is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures. It derives substantially all of its revenue from the sa...
Read More
16.75
0.62
(3.84%)
263.5K
XNAS Volume
XNAS 14 Jan, 2026 4:30 PM (EST)
Board Meeting
The latest board meeting for NeuroPace Inc took place on 14 Jan 2026, for the purpose of NeuroPace to Present at the 44th Annual J.P. Morgan Healthcare Conference
See details
Low Financial Strength
Expensive Valuation
Technically Moderately Bullish
Momentum Trap
These stocks have weak financials and expensive valuation. Buying interest may quickly dissipate. Investors should exercise caution
View Similar
Embed DVM
NeuroPace Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..